Cite
MLA Citation
K. Yip et al.. “62: A retrospective multicentre audit of outcome among patients with anaplastic lymphoma kinase (ALK) gene rearrangement positive non-small cell lung cancer (NSCLC) who have been treated with crizotinib in England.” Lung cancer, vol. 103, n.d., pp. S28–S29. http://access.bl.uk/ark:/81055/vdc_100041521865.0x000034